Skip to main content
. 2022 Oct 19;3(11):100785. doi: 10.1016/j.xcrm.2022.100785

Figure 3.

Figure 3

Biomarker analysis of pathological response in the NAC.NICB cohort

(A) GO and (B) KEGG analysis of differentially expressed genes between response and resistance samples. The enrichment score distribution patterns of (C) 19 immunotherapy efficacy associated signatures, (D) four stromal signatures, and (E) two NAC efficacy associated signatures between response and resistance samples.